Adenosine A2A receptors: localization and function.- Allosteric Mechanisms in the adenosine A2A-dopamine D2 receptor heteromer.- Adenosine A2A receptor antagonists in drug development.- Adenosine A2A Receptors and Neurotrophic Factors: Relevance for Parkinsons Disease.- Role of adenosine A2A receptors in the control of neuroinflammation - relevance for Parkinsons disease.- Purines in Parkinsons: Adenosine A2A receptors and urate as targets for neuroprotection.- Adenosine A2A receptor antagonists as drugs for symptomatic control of Parkinsons disease in preclinical studies.- Dopamine/adenosine interactions related to tremor in animal models of Parkinsonism.- Adenosine A2A receptor antagonists in L-DOPA-induced motor fluctuations.- Adenosine A2A receptor-mediated control of non-motor functions in Parkinsons disease.- Imaging Studies with A2A Receptor Antagonists.- Caffeine and neuroprotection in Parkinsons disease.- The story of istradefylline - the first approved A2A antagonist for the treatment of Parkinsons disease.- Adenosinergic Receptor Antagonists: Clinical Experience in Parkinsons Disease.- Adenosinergic regulation of sleep-wake behavior in the basal ganglia.
